Título :	Combining Glucagon-Like Peptide-1 Receptor agonists and Sodium-Glucose Cotransporter-2 Inhibitors in the management of Type 2 Diabetes Mellitus: A protocol for a scoping review
Tipo de documento :	documento electrónico
Autores :	Carlos Esteban Builes Montaño, Autor ; Suarez Rodriguez, Andres F., Autor ; Carreño, Johanna, Autor
Fecha de publicación :	2025
Títulos uniformes :	F1000Research
Idioma :	Inglés (eng)
Palabras clave :	Diabetes mellitus; Glucagon-like peptide-1 receptor agonists; Sodium-glucose cotransporter-2 inhibitors.
Resumen :	Introduction Diabetes treatment has evolved from solely focusing on glucose control to a more patient-centered approach that includes medications designed to reduce specific risks in addition to managing blood glucose control. Methods and analysis We propose a scoping review to explore the available clinical research on the combined use of GLP-1RAs and SGLT2is. This review will adhere to the guidelines outlined in the Joanna Briggs Institute Reviewer’s Manual and the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews).
Mención de responsabilidad :	Carlos E. Builes-Montaño https://orcid.org/0000-0002-2418-61592,3, Andres F. Suarez-Rodriguez1, Johanna Carreño1
DOI (Digital Object Identifier) :	10.12688/f1000research.159628.1
Derechos de uso :	CC BY-NC-ND
En línea :	https://f1000research.com/articles/14-202
Enlace permanente :	https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis

Combining Glucagon-Like Peptide-1 Receptor agonists and Sodium-Glucose Cotransporter-2 Inhibitors in the management of Type 2 Diabetes Mellitus: A protocol for a scoping review [documento electrónico] / Carlos Esteban Builes Montaño, Autor ; Suarez Rodriguez, Andres F., Autor ; Carreño, Johanna, Autor . - 2025.
Obra : F1000Research

Idioma : Inglés (eng)

Palabras clave :	Diabetes mellitus; Glucagon-like peptide-1 receptor agonists; Sodium-glucose cotransporter-2 inhibitors.
Resumen :	Introduction Diabetes treatment has evolved from solely focusing on glucose control to a more patient-centered approach that includes medications designed to reduce specific risks in addition to managing blood glucose control. Methods and analysis We propose a scoping review to explore the available clinical research on the combined use of GLP-1RAs and SGLT2is. This review will adhere to the guidelines outlined in the Joanna Briggs Institute Reviewer’s Manual and the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews).
Mención de responsabilidad :	Carlos E. Builes-Montaño https://orcid.org/0000-0002-2418-61592,3, Andres F. Suarez-Rodriguez1, Johanna Carreño1
DOI (Digital Object Identifier) :	10.12688/f1000research.159628.1
Derechos de uso :	CC BY-NC-ND
En línea :	https://f1000research.com/articles/14-202
Enlace permanente :	https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis